-

ValGenesis to Kick Off 2026 ValConnect Innovation Day Series in Lisbon

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in digital validation and process lifecycle management, today announced it will kick off its global ValConnect Innovation Day series on May 19, 2026, in Lisbon, Portugal, at the Lux Lisboa Park Hotel.

ValGenesis will kick off its global ValConnect Innovation Day series on May 19, 2026, in Lisbon, Portugal, at the Lux Lisboa Park Hotel.

Share

The event will bring together life sciences leaders, industry experts, and customers for a program focused on how organizations are applying artificial intelligence, digital transformation, and modern validation approaches across the product lifecycle. It will begin with a welcome reception on May 18, followed by ValConnect Innovation Day on May 19, and conclude with hands-on training sessions on the ValGenesis Smart GxP™ platform on May 20.

Attendees will hear real-world case studies from Pharmascience and UCB, highlighting how organizations are scaling digital validation and development initiatives, applying Quality by Design (QbD) and Quality Risk Management (QRM), and driving operational transformation. A VAL™ (ValGenesis AI) customer will provide a firsthand perspective on implementation, including key challenges, outcomes, and lessons learned.

The agenda also includes a panel discussion with industry leaders from Axendia, UCB, Chiesi, and Hansa Biopharma on how emerging technologies are reshaping research, manufacturing, and quality. Interactive discussions, peer networking, and mentoring sessions with ValGenesis experts will provide additional opportunities for attendees to engage directly with speakers and peers.

The Lisbon event is part of the 2026 ValConnect Innovation Day series, with additional events taking place on June 2 in Research Triangle Park, North Carolina, U.S., and Sept. 9 in Mumbai, India.

“ValConnect Innovation Day is designed to create a space where life sciences professionals can learn directly from their peers,” said David Medina, chief marketing officer at ValGenesis. “By bringing together customers, partners, and industry experts, we’re helping organizations share what’s working, navigate common challenges, and apply new approaches with greater confidence.”

To view the full agenda for the Lisbon event, visit https://www.valgenesis.com/valconnect-innovation-day-2026-lisbon. Registration is now open for the Research Triangle Park event.

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com/

Contacts

Media Contact:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 ext.1026
althea.dsylva@valgenesis.com

ValGenesis, Inc.


Release Versions

Contacts

Media Contact:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 ext.1026
althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis, Inc.

Eugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSV

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in enterprise digital validation, announced that Eugia Pharmaceuticals, a global specialty pharmaceutical company, has gone live with ValGenesis to modernize computer system validation (CSV) processes across its sites in India. The deployment will help enhance compliance, improve operational efficiency, and support growth. Hyderabad-based Eugia Pharma, a subsidiary of Aurobindo Pharma, develops and markets complex generics. The...

ValGenesis to Host ValConnect Mumbai Focused on AI-Driven Validation

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in digital validation, will host ValConnect Innovation Day on Sept. 9 at the Hilton Mumbai International Airport, bringing together leaders from life sciences, technology, and manufacturing to examine the role of AI in validation, compliance, and quality across the GxP lifecycle. The one-day event, which concludes the 2026 ValConnect Innovation Day series, will focus on a central challenge facing life sciences organizations: how...

Leading Oncology Injectables Manufacturer Selects ValGenesis to Modernize Equipment Qualification

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in enterprise digital validation and compliance solutions, announced that a specialized Indian pharmaceutical joint venture focused on cytotoxic and oncology drug manufacturing, has selected the ValGenesis validation lifecycle management platform to modernize equipment qualification across its operations in India. The company manufactures injectable and sterile products for regulated global markets, operating state-of-the-...
Back to Newsroom